EP2968313
Lyfjasamsetning
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
17.3.2014EP published:
31.1.2018EP application number:
14712717.9
EP translation filed:
9.4.2018Grant published:
15.5.2018EPO information:
European Patent Register
Max expiry date:
16.3.2034Expiry date:
16.3.2027Next due date:
31.3.2027
Title:
DRUG COMBINATION
Timeline
Today
17.3.2014EP application
31.1.2018EP Publication
9.4.2018Translation submitted
15.5.2018Registration published
16.3.2027Expires
Owner
Name:
Verona Pharma PLCAddress:
Bradley Court, CF10 3DR, Park Place Cardiff, GB
Inventor
Name:
WALKER, Michael J.A.Address:
Vancouver, British Columbia V6T OA8, CA
Name:
CAZZOLA, MarioAddress:
Napoli, IT
Name:
CALZETTA, LuiginoAddress:
Rome, IT
Agent
Name:
Tego ehf.Address:
Pósthólf 8129, 128, Reykjavík,
Priority
Number:
201361799177 PDate:
15.3.2013Country:
US
Classification
Categories:
A61K 31/495, A61K 31/519, A61P 11/00
Annual fees
Number
Paid
Expires
Payer
Number: 5
Paid: 28.2.2018
Expires: 16.3.2019
Payer: Árnason Faktor
Number: 6
Paid: 7.2.2019
Expires: 16.3.2020
Payer: Árnason Faktor
Number: 7
Paid: 18.2.2020
Expires: 16.3.2021
Payer: Árnason Faktor ehf.
Number: 8
Paid: 8.2.2021
Expires: 16.3.2022
Payer: Árnason Faktor ehf.
Number: 9
Paid: 8.2.2022
Expires: 16.3.2023
Payer: Árnason Faktor ehf.
Number: 10
Paid: 8.2.2023
Expires: 16.3.2024
Payer: Árnason Faktor ehf.
Number: 11
Paid: 14.2.2024
Expires: 16.3.2025
Payer: Árnason Faktor ehf.
Number: 12
Paid: 11.2.2025
Expires: 16.3.2026
Payer: Árnason Faktor ehf.
Number: 13
Paid: 9.3.2026
Expires: 16.3.2027
Payer: Árnason Faktor ehf.